Correlation between Standard Clinical Chemistry and Point of Care Testing Analyzers on Hemoglobin A1C Determination

correlation between standard clinical chemistry and point of care testing analyzers on hemoglobin a1c determination

Comparison of costs of hemoglobin A1c determination by point-of-care testing (POCT) and standard hemoglobin A1c analyzer

OBJECTIVE The use of the levels of hemoglobin A1c for the monitoring of glycemic control in patients with diabetes mellitus (DM) is an accepted method of clinical usefulness. A study was performed to assess the relative costs of hemoglobin A1c determination by diagnostic testing at or near the site of patient care (point-of-care testing, POCT) and using the standard hemoglobin A1c analyzer. MET...

Point-of-Care Hemoglobin A1c Testing: An Evidence-Based Analysis.

BACKGROUND The increasing prevalence of diabetes in Ontario means that there will be growing demand for hemoglobin A1c (HbA1c) testing to monitor glycemic control for the management of this chronic disease. Testing HbA1c where patients receive their diabetes care may improve system efficiency if the results from point-of-care HbA1c testing are comparable to those from laboratory HbA1c measureme...

Can We Apply the Control Material from Standard Clinical Chemistry Analyzer for Usage in the Point of Care Testing Analyzer?

Hemoglobin A1c: Clinical applications and analytical considerations

Diabetes Mellitus (DM) is the most common disorder of carbohydrate metabolism. Hyperglycemia is the common feature of DM. Hyperglycemia causes cardiovascular, renal, ocular, and peripheral nerve disorders in patients with diabetes. Glycemic regulation plays an essential role in controlling these complications. Thus, evaluation of the glycemic control status is crucial in the management of DM. H...

Assessing the performance of point-of-care hemoglobin A1c systems.